Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

COVID-19 may cause hair loss due to infection stress or treatments.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Frankincense may help treat COVID-19, but more research is needed.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.